CardioRisk Calculator
Free
1.6.9for iPhone, iPad and more
The University of British Columbia - Okanagan
Developer
1.6 MB
Size
Oct 21, 2023
Update Date
Medical
Category
17+
Age Rating
Age Rating
CardioRisk Calculator Screenshots
About CardioRisk Calculator
CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application.
CardioRisk Calculator™ provides:
-quick calculations on % LDL-C reductions
-concise drug dosage information
-clear snapshot of a patient's CV risk
-options to bring lipid levels to target
-easy identification of familial hypercholesterolemia
This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.
Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):
- Amgen Canada
- Bayer Inc
- Boehringer Ingelheim (Canada) Ltd
- FH Canada
- HLS Therapeutics
- Janssen Inc
- Novo Nordisk Canada
- Sanofi Canada
CardioRisk Calculator™ provides:
-quick calculations on % LDL-C reductions
-concise drug dosage information
-clear snapshot of a patient's CV risk
-options to bring lipid levels to target
-easy identification of familial hypercholesterolemia
This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.
Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):
- Amgen Canada
- Bayer Inc
- Boehringer Ingelheim (Canada) Ltd
- FH Canada
- HLS Therapeutics
- Janssen Inc
- Novo Nordisk Canada
- Sanofi Canada
Show More
What's New in the Latest Version 1.6.9
Last updated on Oct 21, 2023
Old Versions
- UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults - expanded paragraph regarding statin-indicated conditions
Show More
Version History
1.6.9
Oct 21, 2023
- UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults - expanded paragraph regarding statin-indicated conditions
1.6.8
Jun 27, 2023
NEW: Alternate LDL-C Calculator (for high Triglycerides)
1.6.6
Mar 12, 2022
UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
NEW FEATURE: Simple Framingham Risk Score Calculator
NEW FEATURE: Imputed LDL-C Calculator
NEW FEATURE: Simple Framingham Risk Score Calculator
NEW FEATURE: Imputed LDL-C Calculator
1.6.4
Oct 29, 2021
UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
NEW FEATURE: Simple Framingham Risk Score Calculator
NEW FEATURE: Imputed LDL-C Calculator
NEW FEATURE: Simple Framingham Risk Score Calculator
NEW FEATURE: Imputed LDL-C Calculator
1.6.1
Oct 1, 2021
UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
NEW FEATURE: Imputed LDL-C Calculator
NEW FEATURE: Imputed LDL-C Calculator
1.6.0
Sep 10, 2021
UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
1.5.4
Sep 26, 2020
UPDATED FEATURE: Additional unit(mg/g) for Albumin Creatinine Ratio
1.5.3
Aug 12, 2020
UPDATED FEATURE: Diagnosis of apoB dyslipoproteinemias
1.4.0
Dec 20, 2018
-Addition of Niacin/Fenofibrate Treatment field
-The updated Dyslipidemia Risk Calculator now accommodates patients already on lipid therapy in addition to patients new to drug treatment.
-The updated Dyslipidemia Risk Calculator now accommodates patients already on lipid therapy in addition to patients new to drug treatment.
1.3.3
Dec 17, 2017
-Addition of Bruits/AAA/Pulse Deficit fields
-Updated Dyslipidemia Risk Calculator
-Updated FH Calculator
-Misc. logic improvements
-Updated Dyslipidemia Risk Calculator
-Updated FH Calculator
-Misc. logic improvements
1.3.1
Nov 9, 2017
-Updated Dyslipidemia Risk Calculator
-Updated FH Calculator
-Additional Reference Papers
-Fixed stability issue affecting iPad devices
-Updated FH Calculator
-Additional Reference Papers
-Fixed stability issue affecting iPad devices
1.3.0
Nov 7, 2017
-Updated Dyslipidemia Risk Calculator
-Updated FH Calculator
-Additional Reference Papers
-Updated FH Calculator
-Additional Reference Papers
1.2.27
Aug 8, 2017
Addition of Alirocumab 300 mg Q4W to options of PCSK9i drug class.
1.2.26
Jul 24, 2017
Version 1.2.26: Improved French language support. Miscellaneous visual and performance improvements.
This version of CardioRisk Calculator™ is based on the most recent Canadian dyslipidemia guidelines, and guidelines for the diagnosis of familial hypercholesterolemia.
This version of CardioRisk Calculator™ is based on the most recent Canadian dyslipidemia guidelines, and guidelines for the diagnosis of familial hypercholesterolemia.
1.2.24
May 2, 2017
Version 1.2.24: French language support, and miscellaneous visual improvements.
This version of CardioRisk Calculator™ refers to the most recent Canadian dyslipidemia guidelines, and guidelines for diagnosis of familial hypercholesterolemia.
This version of CardioRisk Calculator™ refers to the most recent Canadian dyslipidemia guidelines, and guidelines for diagnosis of familial hypercholesterolemia.
1.2.21
Feb 23, 2017
Version 1.2.21: Improvements for reliability and speed
This version of CardioRisk Calculator™ refers to the most recent Canadian dyslipidemia guidelines, and implements guidelines for diagnosis of familial hypercholesterolemia. Also, additional drug dosage information is provided.
This version of CardioRisk Calculator™ refers to the most recent Canadian dyslipidemia guidelines, and implements guidelines for diagnosis of familial hypercholesterolemia. Also, additional drug dosage information is provided.
1.2.20
Dec 21, 2016
This version of CardioRisk Calculator™ refers to the most recent Canadian dyslipidemia guidelines, and implements guidelines for diagnosis of familial hypercholesterolemia. Also, additional drug dosage information is provided.
1.1.41
Jan 16, 2015
2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult - 2012 recommendations
-plus-
2014 Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease
-plus-
Statin myalgia clinical index score
-plus-
2014 Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease
-plus-
Statin myalgia clinical index score
1.1.40
Oct 8, 2014
2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult - 2012 recommendations
-plus-
2014 Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease
-plus-
2014 Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease
1.1.28
Mar 26, 2014
2012 Update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult - 2012 recommendations
1.1.6
Mar 25, 2013
-Layout changes to the 2012 Canadian Guidelines module.
-Vascular Age ("Heart Age") is calculated in years rather than a range.
-Vascular Age ("Heart Age") is calculated in years rather than a range.
1.1.4
Jan 16, 2013
Includes recommendations based upon the 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
1.0.17
Feb 13, 2012
Update to the Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance Guideline. (English and French)
1.0.15
Jan 31, 2012
Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance
1.0.8
Dec 22, 2010
CardioRisk Calculator FAQ
Click here to learn how to download CardioRisk Calculator in restricted country or region.
Check the following list to see the minimum requirements of CardioRisk Calculator.
iPhone
Requires iOS 12.0 or later.
iPad
Requires iPadOS 12.0 or later.
iPod touch
Requires iOS 12.0 or later.
CardioRisk Calculator supports English
